Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Fatigue 4Depression 3Breast Neoplasms 2Stomach Neoplasms 1Sleep Wake Disorders 1Quality of Life 1Pancreatic Neoplasms 1Pain 1Neoplasms 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Leukemia 1Hodgkin Disease 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Carcinoma In Situ 1Biliary Tract Neoplasms 1Appendiceal Neoplasms 1Anus Neoplasms 1

Interventions

Gemcitabine 18Cisplatin 12Oxaliplatin 7pembrolizumab 6Nivolumab 6Capecitabine 4trametinib 3Fluorouracil 3Bevacizumab 3tremelimumab 2lenvatinib 2durvalumab 2derazantinib 2atezolizumab 2Trastuzumab 2Ramucirumab 2Radiofrequency Ablation 2Panitumumab 2Leucovorin 2Cryosurgery 2zanidatamab 1vandetanib 1tucatinib 1tocilizumab 1telotristat ethyl 1sargramostim 1rucaparib 1regorafenib 1pertuzumab 1milademetan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Biliary Tract Neoplasms × Yoga × Clear all
NCT02489422 2022-10-14

PRO-YOU

Wake Forest University Health Sciences

Phase NA Completed
44 enrolled 28 charts
Gastrointestinal

Anus Neoplasms, Appendiceal Neoplasms, Biliary Tract Neoplasms, Colonic Neoplasms, Depression, Esophageal Neoplasms, Fatigue, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡